Cite this: Alfuzosin Hydrochloride for the Treatment of Benign Prostatic Hyperplasia - Medscape - Jul 15, 2003.

Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...

The Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market has seen significant attention due to the increasing prevalence of prostate-related conditions, particularly among the aging male ...

From left to right: Adam Baumgarten, M.D., Thomas Chi, M.D., James Bryant, M.D. The University of Alabama at Birmingham is growing its robotics portfolio with new technology focused on the treatment ...

BNH Hospital implements Prostatic Urethral Lift (PUL), a minimally invasive solution changing benign prostatic hyperplasia (BPH) treatment in Thailand. PUBLISHED : 14 May 2025 at 10:49 ...

Men with benign prostatic hyperplasia (BPH) are at increased risk for chronic kidney disease (CKD) and kidney stones, according to findings from 2 separate studies. In the first study ...

More than 40 million American men will be affected by benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate, during their lifetime. Chances are pretty good that it will affect ...

BOSTON and YOKNEAM, Israel, April 22, 2025 /PRNewswire/ -- Butterfly Medical, a medical device company focused on alleviating suffering in patients with BPH (Benign Prostatic Hyperplasia ...

Keywords: aging, benign prostatic hyperplasia (BPH), metabolic syndrome (MetS), lipid markers, inflammation, fatty acids derivatives Click here to sign up for free Altmetric alerts about this article.

Teleflex Incorporated (US) is ranked as the second leading player in the Benign Prostatic Hyperplasia Surgical Treatment market. In 2023, The company is contributing a share of 8.0-9.0% in 2023.

The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion in 2024 and an ...